Regen-Cov: A new Covid-fighting cocktail of hope
A US company has come up with a drug that treats as well as prevents Covid — an effective way of treating milder cases of the disease that responds to highly transmissible new variants. It could provide a much-needed complement or alternative to vaccines in the arsenal of weapons against the disease, especially in countries such as SA with its lagging vaccination rollout programme
29 April 2021 - 05:00
The good news just keeps coming for Regeneron Pharmaceuticals, a US biotech company whose potent cocktail of antibodies has been shown to not only treat Covid-19 infections, but also prevent them.
The cocktail, dubbed Regen-Cov, is not a vaccine but an effective treatment for mild to moderate Covid; it also prevents symptomatic Covid among those who have been exposed to it. Not just that, but in recent clinical trials it’s been proven to respond to highly transmissible new Covid variants...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.